Qingfeng won the bid for the fourth batch of national volume based procurement for two products

2021-02-06

On February 3, Shanghai Yangguang Pharmaceutical Purchasing Network officially released the bidding results of fourth batch of national volume based procurement. Jiangxi Shanxiang Pharmaceutical Co., Ltd. (a subsidiary of Qingfeng Pharmaceutical Group) stood out for two products and successfully won the bid, namely Bangkaxin® Es omeprazole magnesium enteric-coated Tablets, and Ligesitai® Sorafenib tosylate tablets.


Bangkaxin® Es omeprazole magnesium enteric-coated Tablets


XW202102062.jpg


Ligesitai® Sorafenib tosylate tablets


XW202102063.png



share
Prev:This is the first article